Abstract
Ibrutinib (IBR) covalently binds to the active site of Bruton's tyrosine kinase (BTK) and is used for the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL). Approximately 5-10% of CLL is complicated by autoimmune cytopenia (AIC), such as autoimmune hemolytic anemia (AIHA). Several cases of AIC have reportedly demonstrated improvement during IBR treatment. However, in our case, the patient developed AIHA during oral IBR treatment. As AIHA is exacerbated by the increased number of CLL cells in the peripheral blood, it may have developed because of disease progression rather than IBR use. This phenomenon may also be attributed to the production of autoantibodies due to increased number of CD5+ B cells. In this case, withdrawal of IBR and administration of rituximab improved hemolysis. If AIHA develops during treatment, its etiology must be examined to confirm the effects of treatment.
References
Oct 1, 1995·British Journal of Haematology·H MyintT J Hamblin
May 26, 2005·Blood·Marc BeyerJoachim L Schultze
Jun 8, 2010·Annals of Hematology·Francisco Javier PeñalverUNKNOWN Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA
Jul 14, 2010·Best Practice & Research. Clinical Haematology·Clive S Zent, Neil E Kay
Dec 14, 2011·Hematology·Jan A Burger
Nov 6, 2012·Leukemia & Lymphoma·Rosa Ruchlemer, Aaron Polliack
Jul 28, 2013·Blood·Jason A DubovskyJohn C Byrd
Jan 15, 2014·Blood·Jennifer A WoyachJohn C Byrd
Jun 11, 2014·American Journal of Hematology·Carlo ViscoFrancesco Rodeghiero
Feb 27, 2015·British Journal of Haematology·Sudhir MandaAlexey V Danilov
Jul 22, 2015·British Journal of Haematology·Tom G RiderJoel A Newman
Oct 8, 2015·Leukemia·K A RogersJ A Jones
Dec 23, 2015·American Journal of Hematology·Kanti R Rai, Preetesh Jain
Jul 3, 2016·Critical Reviews in Oncology/hematology·Lydia ScarfòPaolo Ghia
Oct 27, 2016·Leukemia Research·Stefano Molica, Aaron Polliack
Feb 17, 2017·Case Reports in Oncology·Aliénor GalinierMathieu Puyade
Jul 29, 2017·Journal of Clinical Pharmacy and Therapeutics·C SkrabsA Gessl
Citations
Jun 11, 2021·Annals of Hematology·Ivan KrečakVelka Gverić-Krečak
Aug 17, 2021·The Cancer Journal·Nil Albiol, Carol Moreno
Apr 10, 2019·Acta Haematologica·Ilana LevyTamar Tadmor